Kyle Swanson, MD
Orthopaedic Surgery · Mankato, MNNPI 1790750701
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $492,017 of the $778,018 with a category attached, or 63.2%. Exactech, Inc. accounts for 67.7% of it on its own, with 6 other manufacturers making up the rest. Among orthopaedic surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 319 payments — averaging $2438.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$527K
- Stryker$236K
- Depuy Synthes Products, Inc.$8K
- Medical Device Business Services, Inc.$6K
- Johnson & Johnson$2K
- Aroa Biosurgery Incorporated$138
- plus $29 from 1 others
Across 83 payments — averaging $1721.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$143K
What the payments were for
- Royalty or licence$492,01763%
- Consulting fees$248,32332%
- Travel & lodging$31,8244%
- Food & beverage$5,8531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 69 | $526,891 |
| Stryker | 235 | $235,968 |
| Depuy Synthes Products, Inc. | 6 | $7,587 |
| Medical Device Business Services, Inc. | 2 | $5,904 |
| Johnson & Johnson | 5 | $1,500 |
| Aroa Biosurgery Incorporated | 1 | $138 |
| Zimmer Biomet | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$778,018 in reported general payments places this provider in the 95th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 180 | $423 |
| Methylprednisolone | 35 | $243 |
| Oxycodone Hcl | 45 | $228 |
| Gabapentin | 27 | $188 |
| Tramadol Hcl | 52 | $137 |
| Clindamycin Hcl | 40 | $107 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $104 |
| Cyclobenzaprine Hcl | 27 | $104 |
| Meloxicam | 17 | $28 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mankato
- Daniel BerryRochester$21.5M
- Mark PagnanoRochester$14.8M
- Robert TrousdaleRochester$12.2M
- John SperlingRochester$12.2M
- Shawn O'DriscollRochester$10.5M
- Bryan Den HartogStillwater$9M
- Joseph NesslerSartell$8.6M
- David LewallenRochester$8M
- Rafael SierraRochester$4.9M
- Mark DahlOak Park Heights$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.